Raav vector compositions having tyrosine-modified capsid...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/864 (2006.01) A61K 38/16 (2006.01) A61K 48/00 (2006.01)

Patent

CA 2720097

Disclosed are tyrosine-modified rAAV vectors, as well as infectious virions, compositions, and pharmaceutical formulations that comprise them. Also disclosed are methods of preparing and methods for using the disclosed tyrosine-phosphorylated capsid protein mutant rAAV vectors in a variety of diagnostic and therapeutic applications including in vivo and ex vivo gene therapy, and large-scale production of rAAV vectors.

L'invention concerne des vecteurs rAAV modifiés par la tyrosine, ainsi que des virions infectieux, des compositions et des formulations pharmaceutiques qui les comprennent. L'invention concerne également des procédés de préparation et des procédés d'utilisation desdits vecteurs rAAV mutants à protéines de capside phosphorylées par la tyrosine dans une pluralité d'applications diagnostiques et thérapeutiques, y compris la thérapie génique in vivo et ex vivo, ainsi que la production à large échelle de vecteurs rAAV.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Raav vector compositions having tyrosine-modified capsid... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Raav vector compositions having tyrosine-modified capsid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Raav vector compositions having tyrosine-modified capsid... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1894679

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.